Italy · Delayed Price · Currency is EUR Ligand Pharmaceuticals Statistics
Total Valuation
iVision Tech has a market cap or net worth of EUR 16.14 million. The enterprise value is 24.01 million.
| Market Cap | 16.14M |
| Enterprise Value | 24.01M |
Important Dates
The next estimated earnings date is Thursday, September 25, 2025.
| Earnings Date | Sep 25, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
iVision Tech has 7.80 million shares outstanding. The number of shares has increased by 12.40% in one year.
| Current Share Class | 7.80M |
| Shares Outstanding | 7.80M |
| Shares Change (YoY) | +12.40% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 1.12% |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 230.15 and the forward PE ratio is 80.72.
| PE Ratio | 230.15 |
| Forward PE | 80.72 |
| PS Ratio | 0.95 |
| PB Ratio | 1.51 |
| P/TBV Ratio | 2.52 |
| P/FCF Ratio | 7.49 |
| P/OCF Ratio | 4.93 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.52, with an EV/FCF ratio of 11.14.
| EV / Earnings | 342.27 |
| EV / Sales | 1.41 |
| EV / EBITDA | 9.52 |
| EV / EBIT | 40.56 |
| EV / FCF | 11.14 |
Financial Position
The company has a current ratio of 1.75, with a Debt / Equity ratio of 0.99.
| Current Ratio | 1.75 |
| Quick Ratio | 1.18 |
| Debt / Equity | 0.99 |
| Debt / EBITDA | 4.20 |
| Debt / FCF | 4.91 |
| Interest Coverage | 1.07 |
Financial Efficiency
Return on equity (ROE) is 0.78% and return on invested capital (ROIC) is 2.00%.
| Return on Equity (ROE) | 0.78% |
| Return on Assets (ROA) | 1.25% |
| Return on Invested Capital (ROIC) | 2.00% |
| Return on Capital Employed (ROCE) | 2.41% |
| Revenue Per Employee | 86,325 |
| Profits Per Employee | 356 |
| Employee Count | 197 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 1.55 |
Taxes
In the past 12 months, iVision Tech has paid 17,891 in taxes.
| Income Tax | 17,891 |
| Effective Tax Rate | 20.32% |
Stock Price Statistics
The stock price has increased by +22.89% in the last 52 weeks. The beta is 1.68, so iVision Tech's price volatility has been higher than the market average.
| Beta (5Y) | 1.68 |
| 52-Week Price Change | +22.89% |
| 50-Day Moving Average | 2.23 |
| 200-Day Moving Average | 2.12 |
| Relative Strength Index (RSI) | 32.78 |
| Average Volume (20 Days) | 10,875 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, iVision Tech had revenue of EUR 17.01 million and earned 70,142 in profits. Earnings per share was 0.01.
| Revenue | 17.01M |
| Gross Profit | 9.94M |
| Operating Income | 591,838 |
| Pretax Income | 88,033 |
| Net Income | 70,142 |
| EBITDA | 2.52M |
| EBIT | 591,838 |
| Earnings Per Share (EPS) | 0.01 |
Balance Sheet
The company has 3.61 million in cash and 10.59 million in debt, giving a net cash position of -6.98 million or -0.90 per share.
| Cash & Cash Equivalents | 3.61M |
| Total Debt | 10.59M |
| Net Cash | -6.98M |
| Net Cash Per Share | -0.90 |
| Equity (Book Value) | 10.66M |
| Book Value Per Share | 1.25 |
| Working Capital | 7.00M |
Cash Flow
In the last 12 months, operating cash flow was 3.27 million and capital expenditures -1.12 million, giving a free cash flow of 2.16 million.
| Operating Cash Flow | 3.27M |
| Capital Expenditures | -1.12M |
| Free Cash Flow | 2.16M |
| FCF Per Share | 0.28 |
Margins
Gross margin is 58.48%, with operating and profit margins of 3.48% and 0.41%.
| Gross Margin | 58.48% |
| Operating Margin | 3.48% |
| Pretax Margin | 0.52% |
| Profit Margin | 0.41% |
| EBITDA Margin | 14.83% |
| EBIT Margin | 3.48% |
| FCF Margin | 12.67% |
Dividends & Yields
iVision Tech does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -12.40% |
| Shareholder Yield | n/a |
| Earnings Yield | 0.43% |
| FCF Yield | 13.35% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
iVision Tech has an Altman Z-Score of 1.09 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.09 |
| Piotroski F-Score | 6 |